[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370073-105":59,"doc-detail-370073-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","global-regional-and-national-burden-of-ovarian-cancer-1990-2021-and-projections-to-2050-a-cross-sectional-analysis-of-the-global-burden-of-disease-study-2021","Global, regional, and national burden of ovarian cancer, 1990-2021, and projections to 2050 - a cross-sectional analysis of the Global Burden of Disease Study 2021","","Ovarian cancer remains the most lethal gynecologic cancer, with fewer than half of patients surviving beyond 5 years. This cross-sectional analysis uses Global Burden of Disease Study 2021 data to describe epidemiological trends of ovarian cancer from 1990 to 2021 and to project prevalence through 2050. Incidence, mortality, and disability-adjusted life years rose while prevalence declined, with strong age and regional heterogeneity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-regional-and-national-burden-of-ovarian-cancer-1990-2021-and-projections-to-2050-a-cross-sectional-analysis-of-the-global-burden-of-disease-study-2021/370073/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-regional-and-national-burden-of-ovarian-cancer-1990-2021-and-projections-to-2050-a-cross-sectional-analysis-of-the-global-burden-of-disease-study-2021/370073.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of this study on ovarian cancer?","Question",{"text":113,"@type":114},"To analyze global epidemiological trends of ovarian cancer from 1990 to 2021 and to project its prevalence to 2050, supporting health policy resource use.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which epidemiological measures changed from 1990 to 2021, and how?",{"text":118,"@type":114},"Age-standardized incidence, mortality, and disability-adjusted life years increased, while age-standardized prevalence showed a marked decline.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the projections indicate for 2022 to 2050?",{"text":122,"@type":114},"Age-standardized incidence and prevalence were projected to continue rising, while age-standardized mortality and disability-adjusted life years initially decreased before increasing again.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370073,1790201142,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Global, regional, and national burden of ovarian cancer, 1990–2021, and projections to 2050: a cross-sectional analysis of the Global Burden of Disease Study 2021  \nWeimin Xie, MDa , Shuiping Tang, MDb , Rong Tang, MMc , Liping Li, MMd , Xiaohang Liu, MMe ,*  \nBackground: Ovarian cancer remains the most lethal gynecological cancer, with fewer than 50% of patients surviving more than 5 years after diagnosis. This study aimed to analyze the global epidemiological trends of ovarian cancer from 1990 to 2021 and also project its prevalence to 2050, providing insights into these evolving patterns and helping health policymakers use healthcare resources more effectively.  \nMethods: This study comprehensively analyzes the original data related to ovarian cancer from the Global Burden of Disease Study 2021 database, employing a variety of methods including descriptive analysis, correlation analysis, age–period–cohort analysis, decomposition analysis, predictive analysis, frontier analysis, and health inequality analysis. The aim is to explore the disease burden of ovarian cancer and its changing trends in detail.  \nResults: From 1990 to 2021, the age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and agestandardized disability-adjusted life year rate (ASDR) for ovarian cancer significantly increased, while the age-standardized prevalence rate (ASPR) showed a marked decline. In 2021, theASIR of ovarian cancer was 6.71 per 100 000 population, theASPR was 28.08 per 100 000, the ASMR was 4.06 per 100 000, and the ASDR was 115.15 per 100 000. As the Social Development Index (SDI) increased, the disease burden of ovarian cancer exhibited a trend of rising initially followed by a decline. Health inequalities between countries have slowed, but high-SDI countries remain the primary regions with the greatest disease burden. The age-standardized rates (ASRs) of ovarian cancer increased with age, with population growth being a major driver of the rise in ovarian cancer ASRs. Furthermore, the effects of aging and epidemiological changes vary across different regions. Predictive results indicate that from 2022 to 2050, both the ASIR and ASPR for ovarian cancer will continue to rise, while the ASMR and ASDR will initially decrease before increasing again. High body mass index and occupational exposure to asbestos are the primary risk factors contributing to ovarian cancer.  \nConclusions: Although the disease burden of ovarian cancer showed a downward trend from 1990 to 2021, a potential rebound may occur in the future. The disease burden of ovarian cancer exhibits significant heterogeneity across age, time, and geographical regions. Greater attention to these factors is needed moving forward.  \nKeywords: disease burden, global burden of disease, ovarian cancer, risk factor  \naDepartment of Gynecology, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan Province, China, bDepartment of General Surgery, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan Province, China, cDepartment of Gynecology, Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan Province, China, dNursing Department, Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, Hunan Province, China and eDepartment of Gynecology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China  \nWeimin Xie and Shuiping Tang contributed equally to this work.  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding author. Address: Department of Gynecology, Hainan General Hospital, No. 19, Xiuhua Road, Xiuying District, Haikou City, Hainan Province 570311, China. Tel.: +86 0898 963399. E-mail: [liuxiaohang202000@163.com](liuxiaohang202000@163.com)[ ](liuxiaohang202000@163.com)(","cbCait0GuGP9WcX7","https://ap.wps.com/l/cbCait0GuGP9WcX7","pdf",2486409,13,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the purpose of this study on ovarian cancer?\",\"answer\":\"To analyze global epidemiological trends of ovarian cancer from 1990 to 2021 and to project its prevalence to 2050, supporting health policy resource use.\"},{\"question\":\"Which epidemiological measures changed from 1990 to 2021, and how?\",\"answer\":\"Age-standardized incidence, mortality, and disability-adjusted life years increased, while age-standardized prevalence showed a marked decline.\"},{\"question\":\"What did the projections indicate for 2022 to 2050?\",\"answer\":\"Age-standardized incidence and prevalence were projected to continue rising, while age-standardized mortality and disability-adjusted life years initially decreased before increasing again.\"}]","Global, regional, and national burden of ovarian cancer, 1990-2021, and projections to 2050 - a cross-sectional analysis of the Global Burden of Disease Study 2021 | PDF",1790186582,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02a66290bfd1c442ebd32d81c8abe2ae.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5081a493ae215137527c508a28d93790.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/778e809423094a62d31cf1432a2fa1df.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c38b4aa8bc422413f622843d3f06ce3.webp",980,1306]